Antiplatelet Therapy

University of Maryland Medical Center Launches Genetic-Testing Program For Cardiac Stent Patients

Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center (UMMC) now can receive long-term therapy based on information found in their genes. As part of a new personalized medicine initiative, the med...

FDA Approves Kcentra for the Urgent Reversal of Anticoagulation in Adults with Major Bleeding

The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K antagonist (VKA) anticoagulation in adults with acute major bleeding. 

Newly Approved Blood Thinner May Increase Viral Infections

A study led by researchers at the University of North Carolina indicates a newly approved blood thinner blocks a key component of the human blood clotting system and may increase the risk and severity of certain viral infections, including flu and...

Cangrelor Superior to Clopidogrel in CHAMPION PHOENIX Trial

The experimental anti-clotting drug cangrelor solidly outperformed commonly used clopidogrel in a large global trial of patients who underwent coronary stent procedures, according to data from the phase III CHAMPION PHOENIX study presented at the...

University of Maryland Medical Center Genetic-Testing Program Cardiac Stent
University of Maryland Medical Center Launches Genetic-...
Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center (UMMC) now can receive long-term therapy based on...
FDA Approves Kcentra for the Urgent Reversal of...
The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K antagonist (VKA)...
UK Blood Clots Teststing Wafarin Self Monitoring
Simple Home Test Can Halve the Risk of Stroke for Patients...
A simple self-monitoring test could reduce the risk of stroke by half in thousands of people in the United Kingdom who currently take warfarin to prevent blood...
Accumetrics Inc. VerifyNow P2Y12 Test Bleeding Ischemic Events
Accumetrics Obtains CE Mark for Therapeutic Window Claim on...
Accumetrics Inc. announced an expansion in the intended use for the CE marked VerifyNow P2Y12 Test. Physicians can now use the test results to assess whether a...
FDA Approves Kcentra for the Urgent Reversal of Anticoagulation in Adults with Major Bleeding
The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K
Atherotech Diagnostics Lab Adds Corgenix AspirinWorks Test for Aspirin Effect
Corgenix Medical Corp. has announced that Atherotech Diagnostics Lab will carry its AspirinWorks Test for determining...
Rivaroxaban for Treatment of Deep Vein Thrombosis, Pulmonary Embolism
Rivaroxaban (Xarelto) is an oral anticoagulant for the treatment of deep vein thrombosis (DVT) and/or pulmonary embolism (PE), and to...
View All »

Articles

University of Maryland Medical Center Genetic-Testing Program Cardiac Stent
University of Maryland Medical Center Launches Genetic-...
Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center (UMMC) now can receive long-term therapy based on...
FDA Approves Kcentra for the Urgent Reversal of...
The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K antagonist (VKA)...
Newly Approved Blood Thinner May Increase Viral Infections
A study led by researchers at the University of North Carolina indicates a newly approved blood thinner blocks a key component of the human blood clotting...
CHAMPION PHOENIX clinical study anti-platelet therapy cangrelor ACC 13
Cangrelor Superior to Clopidogrel in CHAMPION PHOENIX Trial
The experimental anti-clotting drug cangrelor solidly outperformed commonly used clopidogrel in a large global trial of patients who underwent coronary stent...

Video Center

view all Videos »

The Radial Access Adoption Report Card
Over the past decade in the United States, there has been growing interest in transradial artery...
11 weeks 23 hours ago
Game-Changing Technologies to Watch in 2013
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
15 weeks 2 days ago
Innovation Exasperation
In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A....
19 weeks 1 day ago
View All »
EP lab, Tom De potter, depotter, angiography dose reduction
Less is More — Radiation Exposure Reduction in the EP Lab
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Iterative Reconstruction in CT: Understanding and Implementation
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
Healthcare Reform: What’s the Immediate Impact on Cardiovascular IT?
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...

Comparison Charts

Sorry there is no data available